Filing Details
- Accession Number:
- 0001387131-20-001050
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-05 18:07:08
- Reporting Period:
- 2020-02-03
- Accepted Time:
- 2020-02-05 18:07:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 25743 | Therapeuticsmd Inc. | TXMD | Pharmaceutical Preparations (2834) | 870233535 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1532232 | Mitchell Krassan | 951 Yamato Road, Suite 220 Boca Raton FL 33431 | Chief Strategy Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-02-03 | 105,703 | $0.19 | 105,703 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-02-03 | 194,297 | $0.20 | 300,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-02-03 | 300,000 | $2.26 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-02-03 | 105,703 | $0.00 | 105,703 | $0.19 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-02-03 | 194,297 | $0.00 | 194,297 | $0.20 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2011-05-01 | 2020-05-01 | No | 4 | M | Direct |
| 489,658 | 2013-09-01 | 2020-09-01 | No | 4 | M | Direct |
Footnotes
- The sales were made pursuant to the Reporting Person's 10b5-1 trading plan dated December 10, 2019 with respect to shares of common stock underlying options to purchase common stock that expire on or before September 2020.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.25 to $2.285, inclusive. The reporting person undertakes to provide TherapeuticsMD, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
